Jim Cramer shines a spotlight on Novo Nordisk A/S (NVO) as "Canada's backdoor" in a recent Insider Monkey report, highlighting the pharma giant's daring strategies and thrilling growth prospects throughout North America
Jim Cramer shines a spotlight on Novo Nordisk A/S (NVO) as "Canada's backdoor" in a recent Insider Monkey report, highlighting the pharma giant's daring strategies and thrilling growth prospects throughout North America
